Federated Hermes Inc. Sells 791 Shares of Exponent, Inc. (NASDAQ:EXPO)

Federated Hermes Inc. cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 15.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,212 shares of the business services provider’s stock after selling 791 shares during the period. Federated Hermes Inc.’s holdings in Exponent were worth $371,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Operose Advisors LLC acquired a new position in shares of Exponent during the 3rd quarter worth $39,000. Signaturefd LLC grew its position in Exponent by 157.7% in the third quarter. Signaturefd LLC now owns 915 shares of the business services provider’s stock valued at $78,000 after acquiring an additional 560 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in Exponent by 10.5% during the third quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock worth $126,000 after acquiring an additional 140 shares in the last quarter. Covestor Ltd lifted its holdings in shares of Exponent by 24.8% in the third quarter. Covestor Ltd now owns 1,474 shares of the business services provider’s stock worth $126,000 after acquiring an additional 293 shares during the last quarter. Finally, Quadrature Capital Ltd boosted its stake in shares of Exponent by 6.7% in the 3rd quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock valued at $210,000 after purchasing an additional 155 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Trading Up 2.1 %

NASDAQ:EXPO opened at $94.33 on Friday. The stock’s 50-day moving average is $81.47 and its 200-day moving average is $82.00. Exponent, Inc. has a 1-year low of $64.61 and a 1-year high of $102.72. The stock has a market cap of $4.78 billion, a P/E ratio of 47.64 and a beta of 0.64.

Exponent (NASDAQ:EXPOGet Free Report) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The firm had revenue of $137.21 million for the quarter, compared to analyst estimates of $125.98 million. During the same period in the previous year, the firm posted $0.56 EPS. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year. As a group, equities analysts forecast that Exponent, Inc. will post 1.92 EPS for the current year.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $1.12 dividend on an annualized basis and a yield of 1.19%. Exponent’s payout ratio is 56.57%.

Insider Buying and Selling

In other Exponent news, insider Eric Guyer sold 3,367 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $78.49, for a total value of $264,275.83. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders sold a total of 5,030 shares of company stock valued at $418,242 in the last three months. Insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

EXPO has been the subject of a number of research analyst reports. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial upped their price target on shares of Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th.

Read Our Latest Research Report on EXPO

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.